How can I differentiate impetigo from herpes simplex type 1 in a perioral rash?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 8, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Differentiating Impetigo from Herpes Simplex Type 1 Around the Mouth

The key distinguishing features are lesion appearance and evolution: impetigo presents with honey-colored crusts on erythematous erosions without vesicles, while herpes labialis shows grouped vesicles that progress to ulcers with a clear prodrome of tingling or pain.

Clinical Differentiation Algorithm

Impetigo Characteristics 1, 2

Lesion appearance:

  • Begins as erythematous papules that rapidly evolve into vesicles and pustules
  • Vesicles rupture within hours, leaving honey-colored crusts on an erythematous base
  • Crusts are thick and adherent
  • Lesions are painless but may be slightly pruritic 3
  • Scattered distribution, not grouped
  • No prodromal symptoms

Location:

  • Commonly affects face and perioral area, but lesions are on exposed skin surfaces
  • Can spread to multiple body regions 3

Associated findings:

  • Regional lymphadenopathy may occur 3
  • Systemic symptoms usually absent (occasionally mild fever)
  • Lesions heal slowly, leaving depigmented areas 2

Herpes Simplex Type 1 Characteristics 4, 5, 6

Lesion appearance:

  • Begins with sensory prodrome (tingling, pain, burning) 6-48 hours before lesions appear
  • Grouped vesicles on erythematous base
  • Vesicles contain clear fluid initially
  • Progress to pustules, then ulcers, then crusts
  • Lesions are painful 4
  • Course of 7-10 days untreated

Location:

  • Typically on lips (vermillion border) and perioral skin 7
  • In recurrent herpes labialis, lesions occur on perioral skin and dry vermillion part of lip, NOT on oral mucosa in immunocompetent patients 7
  • Tender submandibular lymphadenopathy common with primary infection 4

Associated findings:

  • Fever and irritability with primary gingivostomatitis 4
  • Recurrent episodes 1-12 times per year 5
  • Triggered by sunlight or physiologic stress 5

Critical Diagnostic Pitfalls

Important caveat: HSV can present atypically and mimic impetigo, particularly in immunocompromised patients 8. One case report documented disseminated HSV presenting with lesions "resembling impetigo" as the first presentation of AIDS 8. Therefore, if lesions fail to respond to appropriate antibiotic therapy for impetigo, consider HSV infection.

Confirmatory Testing When Diagnosis Uncertain

For suspected HSV 6:

  • First choice: HSV NAAT/PCR from lesion swab (>90% sensitivity and specificity)
  • Must differentiate HSV-1 from HSV-2
  • Sample from active vesicle or ulcer (not crusted lesion, as sensitivity decreases with healing)
  • If PCR unavailable, viral culture is acceptable but less sensitive
  • Type-specific serology if lesions have healed

For suspected impetigo 1:

  • Culture of vesicle fluid, pus, or erosions
  • Establishes whether S. aureus, S. pyogenes, or both

Key Distinguishing Features Summary

Feature Impetigo HSV-1
Prodrome None Tingling/pain 6-48h before
Pain Painless, slightly pruritic Painful
Lesion pattern Scattered individual lesions Grouped vesicles
Crust appearance Thick honey-colored Thin, after ulceration
Vesicle duration Ruptures within hours Persists 1-2 days
Recurrence No (unless reinfection) Yes, same location
Response to antibiotics Resolves No response

The most reliable clinical discriminator is the presence or absence of a painful prodrome followed by grouped vesicles (HSV) versus painless scattered erosions with honey-colored crusts appearing without warning (impetigo). 4, 1, 2, 3, 7

References

Research

Facial and perioral primary impetigo: a clinical study.

The Journal of clinical pediatric dentistry, 2005

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.